NCKAP5

Across TCGA pan-cancer cohorts, NCKAP5 mass-spec protein is linked to patient survival in 2 of 34 cancer types, making it a survival-associated NCKAP5 data layer compared with 24 for mass-spec protein and 10 for mutation status.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher NCKAP5 mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated NCKAP5 expression acts as an unfavorable survival marker.

UCEC and LUAD are the cancer types where NCKAP5 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Tertile	All	0.436	1.000	.034	4	view →
LUAD	OS	Median	All	0.752	1.000	.032	2	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

NCKAP5–UCEC (DFS)

Open the UCEC breakdown →